Cigna Group (CI) Expected to Announce Quarterly Earnings on Thursday

Key Points

• Cigna Group is set to announce its Q3 2025 earnings on October 30th, with analysts predicting earnings of $7.70 per share and revenue of $66.3954 billion.
• The company reported a last quarter EPS of $7.20, exceeding expectations, with revenue up 11.0% compared to the previous year.
• Cigna Group recently declared a quarterly dividend of $1.51 per share, payable on December 18th, reflecting a 2.0% dividend yield.

Cigna Group (NYSE:CI - Get Free Report) is expected to issue its Q3 2025 results before the market opens on Thursday, October 30th. Analysts expect Cigna Group to post earnings of $7.70 per share and revenue of $66.3954 billion for the quarter. Cigna Group has set its FY 2025 guidance at 29.600- EPS.Parties are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, October 30, 2025 at 8:30 AM ET.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business's quarterly revenue was up 11.0% compared to the same quarter last year. During the same period last year, the company posted $6.72 EPS. On average, analysts expect Cigna Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

Cigna Group Price Performance

NYSE CI opened at $308.30 on Thursday. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market capitalization of $82.30 billion, a price-to-earnings ratio of 16.83, a price-to-earnings-growth ratio of 0.90 and a beta of 0.45. The company has a 50 day simple moving average of $298.83 and a 200-day simple moving average of $307.81. Cigna Group has a 52-week low of $256.89 and a 52-week high of $350.00.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group's dividend payout ratio (DPR) is 32.97%.

Insider Activity at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider owned 51,182 shares of the company's stock, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 28,526 shares of the firm's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cigna Group

Hedge funds have recently modified their holdings of the business. Advisory Services Network LLC increased its position in Cigna Group by 18.1% during the second quarter. Advisory Services Network LLC now owns 5,167 shares of the health services provider's stock worth $1,708,000 after acquiring an additional 792 shares during the period. Geneos Wealth Management Inc. grew its position in Cigna Group by 42.5% in the 2nd quarter. Geneos Wealth Management Inc. now owns 2,114 shares of the health services provider's stock worth $699,000 after purchasing an additional 630 shares during the last quarter. Headlands Technologies LLC bought a new position in shares of Cigna Group during the 2nd quarter worth about $564,000. CANADA LIFE ASSURANCE Co raised its position in shares of Cigna Group by 2.8% during the second quarter. CANADA LIFE ASSURANCE Co now owns 395,284 shares of the health services provider's stock valued at $130,853,000 after buying an additional 10,827 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Cigna Group by 169.3% in the second quarter. Tower Research Capital LLC TRC now owns 29,566 shares of the health services provider's stock valued at $9,774,000 after buying an additional 18,586 shares during the period. 86.99% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CI shares. The Goldman Sachs Group started coverage on shares of Cigna Group in a report on Tuesday, October 14th. They set a "buy" rating and a $370.00 price target on the stock. Robert W. Baird set a $372.00 target price on Cigna Group in a research note on Thursday, August 14th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Cigna Group in a research report on Wednesday, October 8th. Wells Fargo & Company lifted their price target on Cigna Group from $340.00 to $354.00 and gave the company an "equal weight" rating in a report on Tuesday, October 7th. Finally, Wall Street Zen downgraded Cigna Group from a "buy" rating to a "hold" rating in a report on Friday, October 3rd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Cigna Group currently has a consensus rating of "Moderate Buy" and an average target price of $369.89.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.